OP026 Comparative effectiveness of vedolizumab and TNF-antagonist therapy in ulcerative colitis: a multicentre consortium propensity score-matched analysis

Antagonist Therapy ◽

Tnf Antagonist

328 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Ulcerative Colitis: A Multicenter Consortium Propensity Score-Matched Analysis

Gastroenterology ◽

10.1016/s0016-5085(18)30723-6 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-82 ◽

Cited By ~ 1

Author(s):

David Faleck ◽

Preeti Shashi ◽

Joseph Meserve ◽

Mahmoud Rahal ◽

Siri Kadire ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Propensity Score ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonist ◽

Antagonist Therapy ◽

Factor Antagonist ◽

Sa1723 - Comparative Effectiveness of Vedolizumab and Tumor Necrosis Factor-Antagonist Therapy in Crohn's Disease: A Multicenter Consortium Propensity Score-Matched Analysis

Gastroenterology ◽

10.1016/s0016-5085(18)31547-6 ◽

2018 ◽

Vol 154 (6) ◽

pp. S-369-S-370 ◽

Cited By ~ 1

Author(s):

Matthew Bohm ◽

Sashivar Sagi ◽

Monika Fischer ◽

Siri Kadire ◽

Gloria Tran ◽

...

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Propensity Score ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonist ◽

Antagonist Therapy ◽

Factor Antagonist ◽

OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.024 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S018-S018 ◽

Cited By ~ 6

Author(s):

M Bohm ◽

S V Sagi ◽

M Fischer ◽

S Kadire ◽

G Tran ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Propensity Score ◽

Tumour Necrosis Factor ◽

Tumour Necrosis ◽

Antagonist Therapy ◽

Tumour Necrosis Factor Antagonist ◽

Factor Antagonist ◽

TNF Antagonist Therapy Tied to Reduced CV Event Rates

Internal Medicine News ◽

10.1016/s1097-8690(11)70276-1 ◽

2011 ◽

Vol 44 (6) ◽

pp. 14

Author(s):

HEIDI SPLETE

Keyword(s):

Antagonist Therapy ◽

Tnf Antagonist ◽

Event Rates

24 REAL-WORLD COMPARISON OF TOFACITINIB VERSUS USTEKINUMAB AMONG ULCERATIVE COLITIS PATIENTS WITH PRIOR ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE: A PROPENSITY SCORE-ADJUSTED ANALYSIS

Gastroenterology ◽

10.1016/s0016-5085(21)00761-7 ◽

2021 ◽

Vol 160 (6) ◽

pp. S-5

Author(s):

Rahul S. Dalal ◽

Jennifer Mitri ◽

Hannah Goodrick ◽

Jessica R. Allegretti

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Propensity Score ◽

Treatment Failure ◽

Tumor Necrosis Factor Alpha ◽

Real World ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Factor Alpha ◽

PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial

Value in Health ◽

10.1016/j.jval.2021.04.126 ◽

2021 ◽

Vol 24 ◽

pp. S24

Author(s):

M.K. Siddiqui ◽

J. Gricar ◽

M. Kurt

Keyword(s):

Squamous Cell Carcinoma ◽

Propensity Score ◽

Esophageal Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Propensity Score Matching ◽

Squamous Cell ◽

Comparative Effectiveness

Comparison of 1-Year Colectomy Risk Between the US and Korean Patients with Acute Severe Ulcerative Colitis: A Propensity Score Matching Analysis

Digestive Diseases and Sciences ◽

10.1007/s10620-021-07130-y ◽

2021 ◽

Author(s):

Eun Soo Kim ◽

Kyeong Ok Kim ◽

Byung Ik Jang ◽

Eun Young Kim ◽

Yoo Jin Lee ◽

...

Keyword(s):

Ulcerative Colitis ◽

Propensity Score ◽

Propensity Score Matching ◽

Severe Ulcerative Colitis ◽

Korean Patients ◽

Propensity Score Matching Analysis ◽

The Us

Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center

Gastroenterology Research ◽

10.14740/gr934w ◽

2018 ◽

Vol 11 (1) ◽

pp. 41-45 ◽

Cited By ~ 12

Author(s):

Chaitanya Allamneni ◽

Krishna Venkata ◽

Huifeng Yun ◽

Fenglong Xie ◽

Lindsey DeLoach ◽

...

Keyword(s):

Ulcerative Colitis ◽

Inflammatory Bowel Disease ◽

Induction Therapy ◽

Real World ◽

Bowel Disease ◽

Inflammatory Bowel

DOP009 Comparative safety profile of vedolizumab and tumour necrosis factor–antagonist therapy for inflammatory bowel disease: a multicentre consortium propensity score-matched analysis

Journal of Crohn s and Colitis ◽

10.1093/ecco-jcc/jjx180.046 ◽

2018 ◽

Vol 12 (supplement_1) ◽

pp. S036-S036 ◽

Cited By ~ 5

Author(s):

D Lukin ◽

A Weiss ◽

S Aniwan ◽

S Kadire ◽

G Tran ◽

...

Keyword(s):

Inflammatory Bowel Disease ◽

Propensity Score ◽

Bowel Disease ◽

Safety Profile ◽

Tumour Necrosis ◽

Antagonist Therapy ◽

Inflammatory Bowel ◽

Comparative Safety ◽

Factor Antagonist ◽

The association between pre-colectomy thiopurine use and risk of neoplasia after ileal pouch anal anastomosis in patients with ulcerative colitis or indeterminate colitis: a propensity score analysis

International Journal of Colorectal Disease ◽

10.1007/s00384-021-04033-2 ◽

2021 ◽

Author(s):

Maia Kayal ◽

Alexa Riggs ◽

Michael Plietz ◽

Sergey Khaitov ◽

Patricia Sylla ◽

...

Keyword(s):

Ulcerative Colitis ◽

Propensity Score ◽

Ileal Pouch ◽

Propensity Score Analysis ◽

Ileal Pouch Anal Anastomosis ◽

Indeterminate Colitis ◽

Score Analysis ◽

Anal Anastomosis